A scientist testing at a laboratory station and looking at the camera

We’re Ready

Explore how we’re Creating Possible at Gilead.

Hear from our Chairman and CEO, Daniel O’Day

RESEARCH AND DEVELOPMENT

Focused on Innovation

A male and female scientist working in a Gilead laboratory

Our goal: Bring 10+ transformative therapies to patients in the next 10 years.

We’re building on our strength in antiviral medicine and our expertise in immunomodulation as we expand into inflammatory diseases and oncology.

Explore our pipeline

Alice Chan, the CEO of The Society for Aids Hong Kong, and another employee are presenting a brochure to their community

Our Rainbow Grant program works to address health disparities by supporting organizations helping improve education and reduce HIV-related stigma.

Meet our grantees

GLOBAL PATIENT ADVOCACY

Supporting Local Communities in the Asia Pacific Region

ADVANCES AGAINST HIV

Taking on HIV Beyond the Lab

Three adult men smiling at a Gilead COMPASS Initiative event

Gilead COMPASS Initiative: $100M to combat HIV/AIDS in the Southern U.S.

Ending the HIV epidemic will take more than just scientific advances. We’re working with our community partners to help address racism, stigma, homophobia and transphobia, particularly in communities disproportionately impacted by HIV.

Learn more about our efforts

Scientist looking at petri dish through a magnifying glass

We are focused on improving the way we work to be more efficient and to minimize our environmental impact. Through efforts like Green Chemistry, we strive to use fewer natural resources while delivering more to our patients around the world.

Meet Our Team

SUSTAINABLE OPERATIONS

Making a Positive and Sustainable Impact

We're Ready for What's Next

The work is already underway. Read Gilead’s 2019 Year in Review to learn more.

Download the report